Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Dow
McKinsey
Express Scripts
McKesson

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Zalutumumab

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Zalutumumab?

Zalutumumab is an investigational drug.

There have been 9 clinical trials for Zalutumumab. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2006.

The most common disease conditions in clinical trials are Head and Neck Neoplasms, Carcinoma, Squamous Cell, and Neoplasms, Squamous Cell. The leading clinical trial sponsors are Genmab, Danish Head and Neck Cancer Group, and [disabled in preview].

Recent Clinical Trials for Zalutumumab
TitleSponsorPhase
Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based ChemotherapyGenmabPhase 1/Phase 2
Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal CancerGenmabPhase 1/Phase 2
Zalutumumab in Non-curable Patients With SCCHNGenmabPhase 2

See all Zalutumumab clinical trials

Clinical Trial Summary for Zalutumumab

Top disease conditions for Zalutumumab
Top clinical trial sponsors for Zalutumumab

See all Zalutumumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Dow
McKesson
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.